Indicated for: invasive candidiasis; fungal infections
Route of administration: infusion
Substance: micafungin (antifungal)
ATC: J02AX05 (Antiinfectives for systemic use | Antimycotics for systemic use | Other antimycotics for systemic use)
Micafunginum is an antifungal medication used for the treatment of invasive fungal infections, such as esophageal candidiasis or systemic fungal infections. It belongs to the echinocandin class and works by inhibiting the synthesis of the fungal cell wall, thereby destroying the fungi.
The medication is administered intravenously, usually once daily, under medical supervision. It is effective in treating severe fungal infections, especially in immunocompromised patients.
Side effects may include nausea, vomiting, fever, headache, and injection site reactions. In rare cases, severe allergic reactions or liver impairment may occur. Close monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Micafunginum. This medication must be administered exclusively in controlled environments, such as hospitals.